
|Videos|October 5, 2017
Addressing Issues Surrounding Current Antibiotic Development
Author(s)Contagion® Editorial Staff
James S. Lewis, PharmD, FIDSA, addresses the issues that surround current antibiotic development.
Advertisement
James S. Lewis, PharmD, FIDSA, Co-Director of Antibiotic Stewardship, Oregon Health and Science University, addresses the issues that surround current antibiotic development. The primary issue involves a common perception shared by some pharmaceutical companies regarding return on investment.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contagion Live
1
CDC's Latest Hepatitis B Vaccine Guidance Serves as Example for Future Federal Vaccine Policy
2
Growing International Evidence Suggests Emerging Metallo-β-Lactamase Therapy Could Benefit US Clinicians
3
Antibiotic De-Escalation Demonstrates Advantages for Community-Onset Sepsis
4
Addressing the Three Pillars of PPE in Caring for Patients with High-Consequence Infectious Disease
5





























































































































































































































































































































